File size: 48,971 Bytes
b4e65c0 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 |
1
00:00:01,580 --> 00:00:06,500
ุจุณู
ุงููู ุงูุฑุญู
ู ุงูุฑุญูู
ุนููุงู ู
ุญุงุถุฑุชูุง ุงูููู
2
00:00:06,500 --> 00:00:13,180
autoimmunity and disease ุงูู autoimmunity ูู ุนุจุฑ
3
00:00:13,180 --> 00:00:16,540
ุฃูุญุงุก ูู
ุฑุถูุฉ ุชูุดุฃ ููู
ู
ุง ูุตูุฑ ููู breakdown of
4
00:00:16,540 --> 00:00:17,360
self tolerance
5
00:00:24,590 --> 00:00:28,070
ุงูู .. ุทุจุนุง ุงูู consequences of autoimmune disease
6
00:00:28,070 --> 00:00:31,570
ุจุชุนุชู
ุฏ ุนูู ุฌุฏุด ุตุงุฑ ููู ุฎูุงู ูู ุงูู self-tolerance
7
00:00:31,570 --> 00:00:34,970
ุงูู
ูุฑูุถ
8
00:00:34,970 --> 00:00:38,950
ุฃูู ูุจู ู
ุง ูุจุฏุฃ ููุฑู ู
ุง ุจูู ู
ุตุทูุญูู ุจูู autoimmune
9
00:00:38,950 --> 00:00:41,390
response ู autoimmune disease ุทุจุนุง ุงูู autoimmune
10
00:00:41,390 --> 00:00:43,890
disease ุนู
ูุญูู ุนููุง ุฅู ุดุงุก ุงููู autoimmune
11
00:00:43,890 --> 00:00:47,090
response ุจุชุนูู ุฃู ูู recognition of self-antigen
12
00:01:04,800 --> 00:01:11,660
ู
ุฑุฉ ุชุงููุฉ ูุจุฏุฃ ุจุณู
ุงููู ุงูููู
ู
ุญุงุถุฑุชูุง ุจุนููุงู
13
00:01:11,660 --> 00:01:15,880
autoimmunity and disease ุงูู autoimmune disease ูู
14
00:01:15,880 --> 00:01:20,470
ุชุนุฑููุง ูู ุนุจุงุฑุฉ ุนู breakdown of self tolerance ู
15
00:01:20,470 --> 00:01:25,010
ุชุจุนุงุช ูุฐู ุงูุญุงูุงุช ุงูู
ุฑุถูุฉ ุจุชุนุชู
ุฏ ุฌุฏุด ุตุงุฑ ููู ุฎูู
16
00:01:25,010 --> 00:01:29,130
ูู ุงูู self-tolerance ูุจุงูุชุงูู ุจูุตูุฑ ูู severity of
17
00:01:29,130 --> 00:01:33,590
disease ูู
18
00:01:33,590 --> 00:01:38,450
ุงูุจุฏุงูุฉ ูุจู ู
ุง ูุจุฏุฃ ูู ูุฐุง ุงูู
ูุถูุน ุจุณ ุจุฏูุง ููุฑู ู
ุง
19
00:01:38,450 --> 00:01:42,870
ุจูู two terms ูุงุญุฏ ุงููู ูู ุงูู autoimmune response
20
00:01:42,870 --> 00:01:45,590
ู autoimmune disease autoimmune disease ุฅู ุดุงุก
21
00:01:45,590 --> 00:01:48,790
ุงููู ููุญูู ูููุง ุงูุชูุตูู ุฏู ุงูู autoimmune responses
22
00:01:49,300 --> 00:01:54,240
ุจุชุนูู ุฃูู ูู recognition of self-antigen ุฃุฏู ุฅูู
23
00:01:54,240 --> 00:01:59,540
pathological consequences ูุจุงูุชุงูู ู
ู ุฎูุงู ุงูุฅูุฑุงุฒ
24
00:01:59,540 --> 00:02:02,940
ุทุจุนุง ุชูููู ุงู
ุง antibody ุฃู complement activation
25
00:02:02,940 --> 00:02:06,880
ุฃู immune complexes formation and cell-mediated
26
00:02:06,880 --> 00:02:07,460
immunity
27
00:02:13,700 --> 00:02:19,640
causes of autoimmune disease ุทุจุนุง ุฃุดูุฑ ูุฐู ุงูุฃุณุจุงุจ
28
00:02:19,640 --> 00:02:23,400
ูู ุงูู genetic susceptibility ู ุทุจุนุง ูุงุญุธููุง ู
ู
29
00:02:23,400 --> 00:02:26,900
ุฎูุงู ุงูู high incidence of autoimmune disease ูู ุงูู
30
00:02:26,900 --> 00:02:31,840
monozygotic twins ู ุทุจุนุง ูู ูุณุจุฉ ุฃูู ูู ุงูู izygotic
31
00:02:31,840 --> 00:02:37,870
and among family member ุฅูุง ุฃูู ูุฐู ุธุงูุฑุฉ ู
ูุฌูุฏุฉ ู
32
00:02:37,870 --> 00:02:42,190
ุจูุนุฑู ูุชูุฑ ู
ู ุงูุญุงูุงุช ุงูู
ุฑุถูุฉ ู
ุดููุฑุฉ ูู ูุซูุฑ ู
ู
33
00:02:42,190 --> 00:02:49,850
ุนุงุฆูุงุช ุงูุจูุฏ ุทุจุนุง ูุฐุง ุจูุชุนูู ูู ุงูู mode of
34
00:02:49,850 --> 00:02:54,830
inheritance generally ู ูุงุญุธูุง ุฃู ุงูู
ูุถูุน ู
ุด ู
ูุถูุน
35
00:02:54,830 --> 00:02:58,730
gene ูุงุญุฏ ูุฅูู
ุง ุนุจุงุฑุฉ ุนู polygenic ุจู
ุนูู ุฃู ูู
36
00:02:58,730 --> 00:03:06,550
ุฃูุซุฑ ู
ู individual gene has to be illicited to
37
00:03:06,550 --> 00:03:10,930
form a disease ู
ู
38
00:03:10,930 --> 00:03:13,790
ุฃุดูุฑ ุงูุฌููุงุช ุงููู ู
ุฑุชุจุทุฉ ุจุงูู autoimmune disease
39
00:03:13,790 --> 00:03:18,130
ุงูู HLA complexes ูุทุจุนุง
40
00:03:18,130 --> 00:03:20,590
ูู ุนูุงูุฉ ู
ุจุงุดุฑุฉ ูุชูุฑ ู
ู ุงูุฃู
ุฑุงุถ ุงููู ูู ุนูุงูุฉ
41
00:03:20,590 --> 00:03:24,410
ู
ุจุงุดุฑุฉ ุจุงูุงู
ุณู ุงูููู ุงููู
42
00:03:26,380 --> 00:03:31,800
ู
ุฑุชุจุท ุจุญุงูุงุช ู
ุฑุถูุฉ ู
ุนููุฉ ููู ูุฐุง ุงููููู ูุฌูุฏู
43
00:03:31,800 --> 00:03:34,960
ุจูุณุชูุฒู
44
00:03:34,960 --> 00:03:39,460
it require other gene to cooperate ุฃู
45
00:03:39,460 --> 00:03:43,660
environmental triggers ู
ุงุดู ูุนูู ูุฌูุฏ ุงูู gene
46
00:03:43,660 --> 00:03:48,600
ุงููููู ูุฐุง ุนูุฏ ุฃู ุดุฎุต ู
ุนูุงุชู ุฃูู ุนูุฏู high
47
00:03:48,600 --> 00:03:53,620
incidence of this disease ููู to become a patient
48
00:03:53,620 --> 00:03:54,800
he has
49
00:04:03,740 --> 00:04:08,600
ุนุดุงู ูุณูุฑ ูู ุญุฏ ูู ุงูู autoimmune disease ุทุจุนุง
50
00:04:08,600 --> 00:04:14,780
ุงูุฏุฑุงุณุงุช ุนูู ุงูู mice ุงุซุจุชุช ุฃู HLA gene can
51
00:04:14,780 --> 00:04:19,120
interfere with many different pathway ูู ุงูู
52
00:04:19,120 --> 00:04:24,440
cellular function ูุจุงูุชุงูู ุจุชุคุฏู ุฅูู autoimmune
53
00:04:24,440 --> 00:04:29,740
disease ุงูุนูุงู
ู ุงูุชู ุชุคุซุฑ ุนูู ุงูู autoimmune disease
54
00:04:29,740 --> 00:04:32,120
ูุงููุง ุงูู over expression ุฃู ุงูู under expression of
55
00:04:32,120 --> 00:04:36,020
ุฌูู ู ุจุงูุฐุงุช ุงูุฌููุงุช ุงูุชู are involved in
56
00:04:36,020 --> 00:04:37,760
apoptosis and cell survival
57
00:04:45,140 --> 00:04:46,120
ูุทุจูุนู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู
58
00:04:46,120 --> 00:04:46,860
ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู
59
00:04:46,860 --> 00:04:50,020
ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู
60
00:04:50,020 --> 00:04:54,620
ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู
61
00:04:54,620 --> 00:04:58,460
ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู
62
00:04:58,460 --> 00:05:01,100
ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู
63
00:05:01,100 --> 00:05:07,420
ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู ุฅูู ุงููุตูู
64
00:05:09,640 --> 00:05:13,020
Deficiency in pro-apoptic molecules ุฒู ุงูู Fas
65
00:05:13,020 --> 00:05:17,980
ู ุงูู Fas Ligand ุฃู ุงูู over expression of anti-apoptic
66
00:05:17,980 --> 00:05:23,640
molecules ุฒู ุงูู BCL2 ููู ุนุจุงุฑุฉ ุนู ุฌูู ุจู code for ุงูู
67
00:05:23,640 --> 00:05:29,390
protein ููุนุจ ุฏูุฑ ูุจูุฑ ูู ุงูู apoptosis Can interfere
68
00:05:29,390 --> 00:05:36,350
the apoptosis ุทุจุนุง ุบูุงุจูู
ุจูุคุฏู ุฅูู diminution of
69
00:05:36,350 --> 00:05:40,430
apoptosis ูุฅุฐุง ุตุงุฑ ูู diminution of apoptosis ุจูุตูุฑ
70
00:05:40,430 --> 00:05:45,630
ููู ุฒูุงุฏุฉ ูู ุงูู auto reactive B and T cell ููุฐุง
71
00:05:45,630 --> 00:05:50,870
ุจูุคุฏู ุฅูู auto antibody production ูุทุจุนุง ุฃุดูุฑ ูุฐู
72
00:05:50,870 --> 00:05:56,870
ุงูู antibody ูู ุงูู antinuclear antibody ุงูู T cell
73
00:05:58,200 --> 00:06:06,500
ู
ูุงุญุธุฉ ุฃุฎุฑู ุชุณูู auto reactivity ูุฌููุง ุฃูุถุง ุจุชุตูุฑ
74
00:06:06,500 --> 00:06:10,360
as a result of expression of pro inflammatory
75
00:06:10,360 --> 00:06:17,550
cytokine ุฒู IL-10 ุฃู excessive costimulation due to
76
00:06:17,550 --> 00:06:26,170
overexpression of B7C28 ู a deficiency of
77
00:06:26,170 --> 00:06:32,490
inhibitor of costimulation reaction ู
ุงุดู ูุจูู ูุฐู
78
00:06:32,490 --> 00:06:41,720
ุจุฑุถู ููุง ุนูุงูุฉ ุจุงูู auto reactive T cell ุฃูุถุง ุงููุนุจ
79
00:06:41,720 --> 00:06:46,700
ูู ุงูู strength of signal transduction ุฒู ู
ุง ูููุง
80
00:06:46,700 --> 00:06:52,620
ุฃูู ุฅุฐุง ูุงู ูู ุฎูู ูู under expression ูู CD 22 ุฃู
81
00:06:52,620 --> 00:07:04,760
over expression ูู CD 19 ุฃูุถุง
82
00:07:11,220 --> 00:07:16,920
Enhanced T Cell Helps
83
00:07:16,920 --> 00:07:21,040
Enhance
84
00:07:21,040 --> 00:07:25,140
Expression Of CD40 To 40-Ligand ุฃูุถุง Similarly
85
00:07:25,140 --> 00:07:33,400
Leads To Auto Antibody Production ู
ูุงุญุธุฉ ุฃุฎุฑู ุฃูุถุง
86
00:07:33,400 --> 00:07:36,500
ุงููู ุนูุงูุฉ ุจุงูู Auto Immune Disease ููู Under
87
00:07:36,500 --> 00:07:39,900
Expression Of Protein ุฒู ุงูู Serum Amyloid Protein
88
00:07:40,350 --> 00:07:43,850
ููุฐุง ุจูุนุจ ุฏูุฑ ูุจูุฑ ูู ุงูู clearance of apoptic
89
00:07:43,850 --> 00:07:46,650
particles ุฃู decreased clearance of immune
90
00:07:46,650 --> 00:07:50,790
complexes ูุงุชุฌุฉ ุนู deficiency of complement
91
00:07:50,790 --> 00:07:57,810
component either C1q, C2, C3 ุฃู even C4 ูู
ุจูุคุฏูุง
92
00:07:57,810 --> 00:08:00,230
ุงูุฏูุฑ ุฅูู ุงูู auto antibody production
93
00:08:08,330 --> 00:08:13,790
ู
ุซุงู ุงูุญูููู ุนูู ูุฐุง ุงูููุงู
ูู ุงูู Neuronal Model
94
00:08:13,790 --> 00:08:21,710
of Autoimmune Myocarditis which revealed that the
95
00:08:21,710 --> 00:08:26,210
disease susceptibility and cardiac damage ุจุชุนุชู
ุฏ
96
00:08:26,210 --> 00:08:31,030
ุนูู Strain-specific cardiac myosin antigen
97
00:08:31,030 --> 00:08:36,110
Accessibility ูุงููุถุน ุงููู ูู ุงูู myosin antigen ูู
98
00:08:36,110 --> 00:08:40,850
ุงูู cardiac tissue
99
00:08:40,850 --> 00:08:46,530
Environmental susceptibility ูุนูู ููู several
100
00:08:46,530 --> 00:08:49,090
environmental factors either infectious ุฃู non
101
00:08:49,090 --> 00:08:53,120
-infectious which can trigger autoimmunity ูููุ
102
00:08:53,120 --> 00:08:56,180
ุฌุงูู by inducing release of sequestered antigen ุฃู
103
00:08:56,180 --> 00:08:59,620
molecular mimicry ุฃู polyclonal activation ูุญูุง
104
00:08:59,620 --> 00:09:03,180
ูุงุฎุฏ ุฃู
ุซูุฉ ุนูู ูุฐุง ุงูููุงู
ูุนูู ุณุจูู ุงูู
ุซุงู ุงูู
105
00:09:03,180 --> 00:09:07,240
autoimmune myocarditis ูุฌุฏูุง ุงููู ูู ุนูุงูุฉ ู
ุจุงุดุฑุฉ
106
00:09:07,240 --> 00:09:12,220
ุจุงูู myocardial infarction ุฃู cardiac ischemic
107
00:09:12,220 --> 00:09:16,160
attack ุดู ุจูุตูุฑ ูููุงุ ุงูู cardiac ischemic attack
108
00:09:16,160 --> 00:09:21,580
ุจูุตูุฑ ููู tissue damage ูุฃ cardiac damage ูุจุงูุชุงูู
109
00:09:21,580 --> 00:09:25,940
ุจูุญุตู ููู sequestered antigen ูููุงุฑุฏู ู
ุณูุฒ ุจูููููุง ุฃู
110
00:09:25,940 --> 00:09:29,600
ุณุจุจ ุงูู autoimmune myocarditis ูู ูุชุฌ ุนู ุขุด ุงูู
111
00:09:29,600 --> 00:09:32,780
consequences of exposure to sequestered antigen
112
00:09:32,780 --> 00:09:39,440
upon heart damage ุฃูุถุง ุงูู autoimmunity may also
113
00:09:39,440 --> 00:09:44,080
arise when an antibody ุฃู T cell specific for
114
00:09:44,080 --> 00:09:48,740
microbial antigen cross react with self-antigen
115
00:09:48,740 --> 00:09:53,080
ุงูู
ุตุทูุญ ุงููุชูุฑ ู
ุดููุฑ ุงููู ูู molecular mimicry ูู
116
00:09:53,080 --> 00:10:01,580
ุชุดุงุจู ู
ุง ุจูููุด foreign antigen ู
ุน self-antigen T
117
00:10:01,580 --> 00:10:08,760
cell dependent self-antigen ูุง ุชุณุชุทูุน ุฃููุง ุชุชู
ุดุท
118
00:10:10,550 --> 00:10:17,790
ุงูู B-cell ูู ุชูููู auto-antibody ูุฃูู
119
00:10:17,790 --> 00:10:22,650
there are no auto-reactive T-cell helper ูุนูู ุงุญูุง
120
00:10:22,650 --> 00:10:25,950
ุจุจุณุงุทุฉ ุจูููู ุฃู ุงูู B ูููุณูุง ุนูุทุด ููู
ู
ุง ุชุตุนุฏ ูู
121
00:10:25,950 --> 00:10:31,990
ูุฑู ุงูุชุฌูู ูุชู
ุดู ุจู ู
ุงุจุชูุฏุฑุด ุชุชูุดุท ููุดุ ูุฃูู ุงูู T
122
00:10:31,990 --> 00:10:39,020
-cell ู
ุทููุจุฉ ุนุดุงู ุชูุดุทูุนูู ู
ุณุงุนุฏุฉ ูุง ุชุชู
ุดุท ุฅูุง
123
00:10:39,020 --> 00:10:42,500
ุจู
ุณุงุนุฏุฉ ุงูู T-Helper Cell ูุบุงูุจุง ุงูู T-Lymphocyte
124
00:10:42,500 --> 00:10:51,280
is either deleted or energized ูุนูู ูู ุงูู primary
125
00:10:51,280 --> 00:10:55,870
lymphoid organs ู
ู ุงูุจุฏุงูุฉ ุงูู T-Lymphocyte is well
126
00:10:55,870 --> 00:11:01,050
educated ูุนูู ุจู
ุนูู ุฃูู ุจุชุชุนูู
ุตุญ ูุงูู
ุญุงุตุฑุฉ
127
00:11:01,050 --> 00:11:04,130
ุงูุชุนููู
ูุงู
ุจุณูู ุงูุฏููุดูู ูู-auto reactive
128
00:11:04,130 --> 00:11:12,910
telephosite ูุงู
ุจุณูู ุงูุฑุฌุฒุช ุงูู
ุดููุฉ
129
00:11:12,910 --> 00:11:18,770
ู
ู
ูู ุชุตูุฑ ูู
ุง ูููู ูุฑู ุงูุชุฌู ุจูุญุชูู ุนูู ุฅูุจูุชูุจ
130
00:11:18,770 --> 00:11:23,790
similar to ุฅูุจูุชูุจ of self-antigen ูุจุงูุชุงูู ูู ูุฐู
131
00:11:23,790 --> 00:11:27,340
ุงูุญุงูุฉ ุจูุตูุฑ ููู ุชูููู ูู auto antibody response
132
00:11:27,340 --> 00:11:35,360
for the foreign antigen ุงููู ุฃูุถุง ู
ู
ูู ูุชูุงุนู ู
ุน
133
00:11:35,360 --> 00:11:39,000
ุงูู self-antigen ูุฃูู ุจูุตูุฑ ููู cross reactivity ูู
134
00:11:39,000 --> 00:11:43,300
ูุฐู ุงูุญุงูุฉ ูุฐุง ู
ุง ูุณู
ู ุจุงูุฅูุด ุจุงูู molecular
135
00:11:43,300 --> 00:11:48,520
mimicry ููุดูู ููุดูู ุฅู ุดุงุก ุงููู ูู ุงูู figure 12.5
136
00:11:48,520 --> 00:11:55,050
ูุฐุง ุงูููุงู
molecular mimicry ูู ู
ุคูุฏ ุฃูู ูุนู
ู ุฑูู
137
00:11:55,050 --> 00:12:02,110
ูู ุงูุฑูู
ุงุชูู ูููุฑ rheumatic fever
138
00:12:02,110 --> 00:12:07,230
ุงูููู
ุชููู ุชูุชุฌ
139
00:12:07,230 --> 00:12:12,350
ู
ู ูุชูุฌุฉ ุงุณุชุฑูุจุชู ูููุงู ุงูููุดู ูุนูู ูู ูู ุจุนุถ ุงูู
140
00:12:12,350 --> 00:12:17,150
cross reactivity ูู ุงูู streptococcal ูุงูู Cardic
141
00:12:17,150 --> 00:12:22,610
Myosin ุงููู ูู ุงูุจุฑูุชูู ูุจุงูุชุงูู ุจุชููู Auto
142
00:12:22,610 --> 00:12:28,610
Antibody which can cross-reactive with the Myosin
143
00:12:28,610 --> 00:12:34,450
in the heart Autoimmune
144
00:12:34,450 --> 00:12:38,190
Diabetes ูู
ุงู ุชููููููุณุงูุช can recognize a peptide
145
00:12:38,190 --> 00:12:45,140
ููุท ุจูุจุชุงูุฏ ู
ู ุงูู glutamic acid D-carboxylase ููุฐุง
146
00:12:45,140 --> 00:12:51,760
ุนุจุงุฑุฉ ุนู ุงูุชุฌู ู
ูุฌูุฏุฉ ูู ุงูู beta islet cell ูู
147
00:12:51,760 --> 00:12:56,700
ูุฐุง ูุงู cross reaction cross react with peptide
148
00:12:56,700 --> 00:13:01,740
derived from kokusaki virus ูุนูู ูู ุชุดุงุจู ู
ุง ุจูู
149
00:13:01,740 --> 00:13:06,420
ุงููู ูู ุงูู kokusaki virus ูู
ุง ุจูู a glutamic acid
150
00:13:06,420 --> 00:13:12,110
ุงููู ูู ุงูู b cell ุจู islet cell ุงููู ูู ู
ู ุฎูุงู
151
00:13:12,110 --> 00:13:17,530
Glutamic Acid Carboxylase Antigen ุฃูุถูุง ุจูุตูุฑ ููู
152
00:13:17,530 --> 00:13:23,750
molecular mimicry ูุทุจุนูุง ุงูู autoimmune disease can
153
00:13:23,750 --> 00:13:27,270
be developed
154
00:13:27,270 --> 00:13:35,270
ุจุนุฏ ู
ุง ูุตูุฑ ููู microbial infection ููู ู
ุซููุง ุฒู
155
00:13:35,270 --> 00:13:38,760
ู
ุง ุฃูุชู
ุดุงูููู ูู ุนุจุงุฑุฉ ุนู auto-reactive B
156
00:13:38,760 --> 00:13:47,120
lymphocytes ู
ุงุณูุฉ ูู self-antigen ูุงูู self
157
00:13:47,120 --> 00:13:52,860
-antigen ุฏู ูู ูู ู
ููุฑูุจูุง ุงูู antigen ุจูุดุชุฑู ู
ุนุงู
158
00:13:52,860 --> 00:13:58,440
ูู ุฅูุจูุชูุจ ุจูุดุชุฑู ู
ุนุงู ูู ุฅูุจูุชูุจ ุทุจุนูุง ุงูู B
159
00:13:58,440 --> 00:14:06,380
lymphocytes ุชุชู
ุดุท for the foreign part ูุชุตุจุญ ูุดุทุฉ
160
00:14:06,380 --> 00:14:11,180
ูุนูุฏู
ุง ุชุตุจุญ ูุดุทุฉ ุชุตุจุญ ูุดุทุฉ ููุง ุชููููููุณุงูุฏุณ ููุงุณ
161
00:14:11,180 --> 00:14:19,400
ูู
ูู ุงููุฑู ุงุจุชุฏูุง which can cause react with the
162
00:14:19,400 --> 00:14:24,900
self ุงุจุชุฏูุง ุชุทูุน auto antibody which can react ู
ุน
163
00:14:24,900 --> 00:14:29,900
ุงูู self ูู
ุน ุงููุฑู ู
ุน ุงูู self ูู
ุน ุงููุฑู
164
00:14:31,960 --> 00:14:36,540
ุทุจุนูุง ูุฐุง ูู ุงููุถุน ุงููู ูููุง ุฃูู ูู common ุฅูุจูุชูุจ
165
00:14:36,540 --> 00:14:43,440
ูู ุงูู foreign antigen ู
ุน ุงูู ash ู
ุน ุงูู self antigen
166
00:14:43,440 --> 00:14:47,400
ูุจุชุชูุดุท ุทุจุนูุง ุชููููููุณุงูุช ููู foreign ุฅูุจูุชูุจ ูุชูุดุท
167
00:14:47,400 --> 00:14:51,580
ุงูู naive ุชููููููุณุงูุช ุจูููู
ููุณุงูุช ูุจูููู
ููุณุงูุช ุชุทูุน
168
00:14:51,580 --> 00:14:57,240
antibody for both self and ash and foreign antigen
169
00:14:58,250 --> 00:15:00,590
ุงูุญุงุฌุฉ ุงูุชุงูุชุฉ ุงููู ุงุญูุง ุฅู ุดุงุก ุงููู ููุญูู ุนูููุง
170
00:15:00,590 --> 00:15:04,910
ุฒู ู
ุง ุฃูุชู
ุดุงูููู ููู
ู
ุง ูุตูุฑ ููู polyclonal
171
00:15:04,910 --> 00:15:09,770
polyclonal ูุนูู ุฃูุซุฑ ู
ู clone ุฃู ุจู ุณู ุงูุชูุงุดููู
172
00:15:09,770 --> 00:15:15,010
ุดู ุงููู ุจูุตูุฑุ ูุนูู ุจุชููู ุดูุก ุจูููู
auto reactive
173
00:15:15,010 --> 00:15:22,230
clone ูุฏู ูู ุงูู auto reactive cell ูู ููู
ู
ุง ูุฎุด big
174
00:15:22,230 --> 00:15:26,510
antigen ุฒู ุงูู limopolysaccharides ู
ุงุดูุ which has
175
00:15:26,510 --> 00:15:32,680
ability to act as a super antigen ูุจุงูุชุงูู ุจุฑูุญู ูู
176
00:15:32,680 --> 00:15:40,540
ู
ุฑุชุจุท ู
ุงุดู ูุทุจุนูุง
177
00:15:40,540 --> 00:15:48,820
ุจุงูู receptor ุนูู ุณุทุญ ุงูู ash ุจูุฑููููุณุงูุช ุซู
ุจู ูุงู
178
00:15:48,820 --> 00:15:53,780
ุจู associate with ุทูู ุงูู coreceptor ูุทูู ุงูู coreceptor
179
00:15:53,780 --> 00:15:58,750
ุจูุนู
ู signal transaction ูุจูุดุท ุงูู ash ุงูุนูุจ ุฃู
180
00:15:58,750 --> 00:16:02,490
ุจูุฑูุณุง ูุฑูุช ุจุชุจุช ุจุฑุณูุจุชูุฑ ู
ุฑุชุจุท ุจุงูุทูุนู ูุฑุณูุจุชูุฑ
181
00:16:02,490 --> 00:16:05,210
which has the ability to induce signal
182
00:16:05,210 --> 00:16:11,250
transduction ูู
ุญุตูุชูุง
183
00:16:11,250 --> 00:16:15,830
activation of cell ุทุจุนูุง ููู
ูุตูุฑ ููู ุฃูุซุฑ ู
ู ูููู
184
00:16:15,830 --> 00:16:19,210
activated ูู
ู ุถู
ููู
auto reactive clone it will
185
00:16:19,210 --> 00:16:27,140
induce autoimmune disease ูู ุงูู Polyclonal
186
00:16:27,140 --> 00:16:31,120
Activation ุงูู Polyclonal Activator ูู
ูู ุฃู ูุฎูู
187
00:16:31,120 --> 00:16:33,020
ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู
188
00:16:33,020 --> 00:16:35,660
ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู
189
00:16:35,660 --> 00:16:36,520
ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ
190
00:16:36,520 --> 00:16:36,820
ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู
191
00:16:36,820 --> 00:16:37,600
ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู
192
00:16:37,600 --> 00:16:38,440
ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู
193
00:16:38,440 --> 00:16:39,820
ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ
194
00:16:39,820 --> 00:16:42,420
ูุฎูู ุงูู
ุงู ุจุดูู ู
ุญุฏุฏ ููุญุตู ููู autoimmune disease
195
00:16:42,420 --> 00:16:45,700
ู
ุซู ู
ุง ูููุง ู
ู ูุจู ูููุช ุจูููู ู
ุงูู ุจูุชูุฑูุงู ุฃู
196
00:16:45,700 --> 00:16:49,620
viral antigen can behave as a super antigen
197
00:16:49,620 --> 00:16:52,560
ูุจุงูุชุงูู it will activate different clone of T
198
00:16:52,560 --> 00:16:59,760
cell ุจุบุถ ุงููุธุฑ ุนู ุงูู specificity ูู ูุฐู ุงูุญุงูุฉ
199
00:16:59,760 --> 00:17:05,240
ุทุจุนูุง ุชุทุจู ู
ุน ุงูู VB gene domain ุงููู ุจูููู ู
ูุฌูุฏ
200
00:17:05,240 --> 00:17:07,380
outside the peptide binding domain
201
00:17:10,810 --> 00:17:16,630
ู
ุงูู ููุฒูุฑุฏ ู
ููููู ูุงุฑุณุชูุชุดุงุฑ ุงููู ูู ุงูู BAMs ุงููู
202
00:17:16,630 --> 00:17:19,330
ู
ูุฌูุฏุฉ ุนูู ู
ุงููุฑู ุฃูุฑุฌุงููุฒู
ุงููู ูู ุงูู BAMs
203
00:17:19,330 --> 00:17:21,990
ุณู
ููุงูุง pathogen associated molecular pattern
204
00:17:21,990 --> 00:17:26,750
ุจุชูุนุจ ุฏูุฑ ูุจูุฑ ูุงูุงุด ูู polyclonal activator ูู ุจู
205
00:17:26,750 --> 00:17:31,110
ุณูู ุทุจุนูุง ุจุชุนุชุจุฑ ุงูุชูุณูุชุฑ ูู ูุฐู ุงูุญุงูุฉ pattern
206
00:17:31,110 --> 00:17:36,270
recognition molecule ุงููู ู
ุฑุชุจุท ุจุงูู BAMB ูุจูุดุทุฑูุง
207
00:17:36,270 --> 00:17:40,130
ุงูู B-lymphocyte as well as other ุทุจุนูุง cell,
208
00:17:40,670 --> 00:17:45,610
lipopolysaccharides can polychronally activate ุงูู
209
00:17:45,610 --> 00:17:49,950
mouse B-cell ุจู
ุง ูููุง ุงูู auto-reactive B-cell ู
ู
210
00:17:49,950 --> 00:17:53,730
ุฎูุงู interaction with receptor on the cell surface
211
00:17:53,730 --> 00:18:01,270
ุงููู ู
ุฑุชุจุท ุจุชููุนู receptor 4 ุดููุงูุง ูู ุงูุงุดูุงุก ุทุจุนูุง
212
00:18:01,270 --> 00:18:08,090
ุงูููู
ุจูููููุง ุฃูู ุฃุญุฏ ุงููุธุฑูุงุช ุงูู
ุทุฑูุญุฉ ุฃูู ุงูู
213
00:18:08,090 --> 00:18:10,770
innate signaling through toll-like receptors
214
00:18:10,770 --> 00:18:15,190
pathway may be a mechanism for activating
215
00:18:15,190 --> 00:18:20,070
energetic B cell ุญุชู ุงูู energetic B cell can be
216
00:18:20,070 --> 00:18:27,790
activated trigger
217
00:18:27,790 --> 00:18:32,900
of autoimmunity ุฅูุด ูู ุงูุนูุงู
ู ุงููู ุงุญูุง ูููุง ุจุฃููุง
218
00:18:32,900 --> 00:18:37,340
environmental factor ุฏู ุงูู trigger ุงููู ูู ุฅู ุฃูุง
219
00:18:37,340 --> 00:18:42,860
ุฃุฎูุฑ chemical substance ููุฑู
ูู ูู ุงูู SLE ุจูููููุง ูู
220
00:18:42,860 --> 00:18:46,720
is ten times more common in women than in men
221
00:18:46,720 --> 00:18:52,700
ูุงูุณุจุจ ูู ุฐูู ุงูุงุณุชุฑูุฌูู Searching drug can
222
00:18:52,700 --> 00:18:56,780
chemically alter T cell carrier epitope of a self
223
00:18:56,780 --> 00:19:01,750
-antigen to render it immunogenic ุชุญูู ุงูู self
224
00:19:01,750 --> 00:19:08,750
-antigen ุฅูู immunogenic antigen ูุตู ุณุจุฑูุณูู T
225
00:19:08,750 --> 00:19:14,990
cell TS can contribute to autoimmune disease ูู
226
00:19:14,990 --> 00:19:22,750
ุทุจุนูุง ุช ุงุณู
ุดุงูููููุง ูู T suppressor cell which can
227
00:19:22,750 --> 00:19:27,330
suppress the activity of both CD4 and CD8 ูุทุจุนูุง
228
00:19:27,330 --> 00:19:31,840
ุบูุงุจูุง ููุคุฏู ุฅูู cell related immunity ุจูุซุฑุฉ which
229
00:19:31,840 --> 00:19:35,080
can lead to autoimmune disease ูุนูู ูุดุชุบู ูุซูุฑ
230
00:19:35,080 --> 00:19:37,980
ูุจุงูุชุงูู ุจุชุบูุท ูุซูุฑ ูุจุงูุชุงูู ุจูุตูุฑ ููู autoimmune
231
00:19:37,980 --> 00:19:41,300
disease ุงููุงุณ ุงููู ุนูุฏูู
diabetes ูุนูุฏูู
232
00:19:41,300 --> 00:19:46,080
inflammatory bowel syndrome ุฃูุถูุง ุนูุฏูู
ููุฉ ูู ุงูู
233
00:19:46,080 --> 00:19:51,680
TS cell ูุงุฎุฏ
234
00:19:51,680 --> 00:19:56,660
ุฃู
ุซูุฉ ุนูู ุงูู autoimmune disease ูุทุจุนูุง ูุจุฏุฃ ุจุงูู
235
00:19:57,940 --> 00:20:04,020
ุฃู
ุซูุฉ ุฃู ุงูุฃู
ุฑุงุถ ุงููู ุจูููู ุงูู antibody ูู ุฏูุฑ
236
00:20:04,020 --> 00:20:13,000
ุฃุณุงุณู ูู ุงูู organ damage ูุฃุดูุฑูุง ูุฐู ุฃู ุจุฏุงูุฉ
237
00:20:13,000 --> 00:20:16,720
ูุจุฏุฃ ุจุงูู autoimmune hemolytic anemia ูููุง ุจูุนุฑู
238
00:20:16,720 --> 00:20:20,860
ุฃูู ุจูุชููู auto antibody against RBCs antigen
239
00:20:20,860 --> 00:20:25,700
ูุจุงูุชุงูู ุจูุตูุฑ ููู ููุฉ ูู ุนุฏุฏ ุงูู RBCs ูุฃููุง ุจุชุชูุณุฑ
240
00:20:26,980 --> 00:20:31,480
ูุงูุชูุณูุฑ ููุชู
ู
ู ุฎูุงู two mechanism ุงูุฃููุงูู ู
ู
241
00:20:31,480 --> 00:20:36,100
ุฎูุงู activation of complement cascade ูุงู
ูุฉ ูุนูู
242
00:20:36,100 --> 00:20:42,000
ููุขุฎุฑ ูู
ุญุตูุชู eventual license of the cell ููุฐุง
243
00:20:42,000 --> 00:20:47,840
ุบุงูุจุงู ุจูุดูู hemoglobin or urea ุจูุถูุญ ุนูุฏ ุงูู
ุฑูุถ
244
00:20:47,840 --> 00:20:53,260
ู
ููุงููุฒู
ุงูุซุงูู ูู ุฃูู ูุตูุฑ ููู optionization ู
ู
245
00:20:53,260 --> 00:21:00,290
ุฎูุงู ุฃู ุงูู C3P ุนูู ุณุทุญ ุงูู RBCs ููุคูุงุก ูุฏููู
246
00:21:00,290 --> 00:21:03,570
ุฑูุณุจุชูุฑ ุนูู ุณุทุญ ุงูู
ุงูุฑูููุฌู ุงูู
ูุฌูุฏุฉ ูู ุงูู
247
00:21:03,570 --> 00:21:06,670
reticulum nucleus system ูุนูู ูู ุงูู Spleen
248
00:21:06,670 --> 00:21:10,930
ูุจุงูุชุงูู ุฃูู ู
ุง ุชุตู ุณูุญุตู ููู Antibody-coated RBCs
249
00:21:10,930 --> 00:21:17,550
recognition ุฃู complement-coated RBCs recognition
250
00:21:17,550 --> 00:21:21,850
ูุงูู
ุญุตูุฉ ูุงูุจูุตูุชูุณูุฒ ูdestruction of the cell
251
00:21:24,650 --> 00:21:28,630
ูุงู ุงูุงูุชูุจุงุฏู ุงูู
ุณุฆูู ุนู ุงูู autoimmunohepatic
252
00:21:28,630 --> 00:21:33,610
anemia ูุชู
ู
ูุงุทุนู ุฅูู ุงุชุฌุงุฑุงุช ุชุฌุงุฑูุฉ
253
00:21:33,610 --> 00:21:35,170
ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ
254
00:21:35,170 --> 00:21:37,310
ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ
255
00:21:37,310 --> 00:21:38,850
ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ
256
00:21:38,850 --> 00:21:39,590
ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ
257
00:21:39,590 --> 00:21:40,050
ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ
258
00:21:40,050 --> 00:21:48,030
ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑููุฉ ุชุฌุงุฑ
259
00:21:48,670 --> 00:21:52,850
ุบุงูุจุง ุจูุฑุชุจุทูุง ู
ุน ุงูู RBCs ููุท ูู
ุง ุชููู ุฏุฑุฌุฉ
260
00:21:52,850 --> 00:21:57,170
ุงูุญุฑุงุฑุฉ ุฃูู ู
ู ุณุจุนุฉ ูุซูุงุซูู ุฏุฑุฌุฉ ู
ุฆููุฉ ู ุจููููุง
261
00:21:57,170 --> 00:22:01,770
ูุนูู ุจูุณูุจูุง ุงูู RBCs ููู
ุชุฑุชูุน ุฏุฑุฌุฉ ุงูุญุฑุงุฑุฉ they
262
00:22:01,770 --> 00:22:05,390
are IgM type and they are highly efficient in
263
00:22:05,390 --> 00:22:09,430
activating complement ูุจุงูุชุงูู ุงูู
ุญุตูุฉ licenses
264
00:22:09,430 --> 00:22:10,470
of RBCs
265
00:22:12,920 --> 00:22:16,220
ุงููุงุฌูุฉ ุฏูููุช ุฃูุถุง ุฌููุชู ุฃููู
ูุง ูู
ูู ุฃู ุชููู ุงูุฏูุฒุช
266
00:22:16,220 --> 00:22:21,460
ุจุจุนุถ ุงูุฃุฏููุฉ ู
ุซู ุงูุจูุณููู ูุงูุฃููุง ู
ุซุงู ุฏูุฑุจุง
267
00:22:21,460 --> 00:22:28,780
ูุจุนุถ ุงูู
ุฑุงุช ุจููุงูู cold antibody ุชูููุช ุจุนุฏ ุงูููุงุด
268
00:22:28,780 --> 00:22:36,340
ู
ุน ุงูุชูุงุจ ุฑุฆูู ุฃู ุจุนุถ ุงูููุฑูุณุงุช ุงูู
ุฑุถูุฉ
269
00:22:36,340 --> 00:22:41,950
ุงูุชุงูู ูู myasthenia gravis ุทุจุนุง ูู ูุฐู ุงูุญุงูุฉ ุงู
270
00:22:41,950 --> 00:22:48,330
target self-antigen ูู ุงูู Acetylcholine receptor ู
271
00:22:48,330 --> 00:22:52,950
ุทุจุนุง ูู ูุฐู ุงูุญุงูุฉ ู
ูุฌูุฏ ุนูู ุงูู neuromuscular
272
00:22:52,950 --> 00:22:56,970
junction ูู ุงูู Acetylcholine ู
ุญุชูู ุงู
273
00:22:56,970 --> 00:23:00,270
neuromuscular junction ู ุจุงูุชุงูู ู
ูุฌูุฏ ุนูู ุงู
274
00:23:00,270 --> 00:23:04,190
muscle cell ู ุจุงูุชุงูู ุงูู auto-antibody ุงููู ุจูุชููู
275
00:23:04,190 --> 00:23:08,080
ุจููุนุจ ุฏูุฑ ูุจูุฑ as antagonist ุจุนู
ู Blocking ููู
276
00:23:08,080 --> 00:23:11,440
Acetylcholine Receptor ููู
ุง ุจูุฌู ุงูู Acetylcholine
277
00:23:11,440 --> 00:23:16,810
ูุดุชุบู ุจููุงูู ุงูู Receptor ู
ุดุบูู ูุจุงูุชุงูู ู
ุง ุจูุตูุฑ
278
00:23:16,810 --> 00:23:23,570
ููู neuromuscular junction ูุนูู ู
ุง ุจูุตูุฑ ููู
279
00:23:23,570 --> 00:23:28,070
muscle function ูุจุงูุชุงูู ุจูุตูุฑ ููู weakness ูุทุจุนุง
280
00:23:28,070 --> 00:23:33,850
ูุฐู ู
ุญุตูุชูุง ุทุจุนุง ู
ู ู
ุธุงูุฑูุง ู ุจูุตูุฑ difficulty in
281
00:23:33,850 --> 00:23:38,510
chewing, swallowing ู breathing ู ูู ุงูููุงูุฉ
282
00:23:38,510 --> 00:23:42,010
ุจูุตูุฑ ููู respiratory failure and death
283
00:23:44,940 --> 00:23:52,100
ุงูุนููุงู ูุจุฏู ุฃูู ู
ุฑุชุจุท ุจุงูู Thymus ุงูู
ุฑูููุงุช
284
00:23:52,100 --> 00:23:57,440
ุงูู
ุชุนุงู
ูุฉ ู
ุน ุงูู Acetylcholine Receptor ู
ูุฌูุฏุฉ ูู ุงูุนุฏูุฏ ู
ู
285
00:23:57,440 --> 00:24:02,440
ุงูุฃุฌุณุงู
ูู ุงูู Thymus ู
ุซู ุงูู Thymocytes ู ุงูู
286
00:24:02,440 --> 00:24:07,300
Epithelial cells ููู
287
00:24:07,300 --> 00:24:12,560
ุทุจุนุง ูู ุตูุฑุฉ ูุงุถุญุฉ ุฌุฏุง ุงูุงูุชูุจุงุฏู ู
ุงุดู
288
00:24:14,400 --> 00:24:28,100
ุฅูุด ุนู
ูุช ูู ูุฐู ุงูุญุงูุฉุ ุนู
ูุช Blocking ููู Receptor
289
00:24:28,100 --> 00:24:30,480
ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด
290
00:24:30,480 --> 00:24:30,520
ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด
291
00:24:30,520 --> 00:24:35,720
ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด
292
00:24:35,720 --> 00:24:36,500
ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด
293
00:24:36,500 --> 00:24:41,240
ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด ูุฅูุด
294
00:24:41,240 --> 00:24:42,000
ูุฅ
295
00:24:44,510 --> 00:24:47,250
ูู ุงูู Graves Disease ุงูู Antibody is stimulating
296
00:24:47,250 --> 00:24:50,610
ููุง ุงูู Antibody is inhibiting Antibody ููุง
297
00:24:50,610 --> 00:24:54,930
Stimulating Antibody ุจูุนุจ ุฏูุฑ ูุจูุฑ ุงุฒ ู
ู
ุณู ูู TSH
298
00:24:54,930 --> 00:25:00,650
Receptor ู TSH ู
ู ุงุญูุง ุจูุนุฑู ุงูู ุงูุด ู ู
ููู
ุจุฏูุฑู
299
00:25:00,650 --> 00:25:04,410
ุทุจุนุง ุจูุนุฑู ุงูู ุจุนู
ู activating ููู thyroid follicle
300
00:25:04,410 --> 00:25:09,010
ู ุจุชุทูุน ุงููุง thyroid hormone ูุจุงูุชุงูู ู
ุญุตูุฉ ุงููู
301
00:25:09,010 --> 00:25:15,330
ูู ุงูู Graves Disease ูู Hyperthyroidism ู
ุงุดู ูุฏู
302
00:25:15,330 --> 00:25:21,310
ุชุญูู ูุดูู ุงูู disease ูููููุง ูู hyperthyroidism
303
00:25:21,310 --> 00:25:27,870
antibody directed against a hormone receptor ุงููู
304
00:25:27,870 --> 00:25:34,290
ุจูุนู
ู ุนูู ุชูุดูุท ุงูู receptor ูุจุงูุชุงูู ุงูู
ุญุตูุฉ ุทุจุนุง
305
00:25:34,290 --> 00:25:37,830
ุงูู hormone ูู thyroid stimulating hormone ู ุงู
306
00:25:37,830 --> 00:25:44,630
interaction ุจูุคุฏู ุงูู ุงููู ูู ูุดุงุท ุงูุบุฏุฉ ูุฃูู
307
00:25:44,630 --> 00:25:50,490
ูุชุจุนู ูู agonist ูู
ุญุตูุชู ุทุจุนุง hyperthyroidism
308
00:25:50,490 --> 00:25:59,250
ุงูุฃุณุฆูุฉ E ุจุฑุถู autoimmune disease ู
ุดููุฑ ุจุงุณู
Red
309
00:25:59,250 --> 00:26:05,930
wolf ุงููู ูู ุงูุฐุฆุจ ุงูุฃุญู
ุฑ ุทุจุนุง ูุชูุฌุฉ ุงูู reddish
310
00:26:06,300 --> 00:26:11,360
facial rash ุงููู ู
ูุฌูุฏุฉ ุนูู ุงูู cheeks ู ุฏู ุบุงูุจุง
311
00:26:11,360 --> 00:26:18,380
ุจุชุนุชุจุฑ early symptoms ูู ูุฐู ุงูุญุงูุฉ ุงูู disease
312
00:26:18,380 --> 00:26:23,940
ุทุจุนุง attacks many organs of the body ูุจูุณุจุจ fever,
313
00:26:24,100 --> 00:26:26,900
joint pain, damage to the central nervous system,
314
00:26:27,220 --> 00:26:31,920
to the heart, to the kidney ูุจุงูุชุงูู ูู ุนุถู ุงูุฌุณู
315
00:26:31,920 --> 00:26:36,570
ู
ู
ูู ูุตูุจู damage ูู
ุญุตูุชู ุทุจุนุง ููุงุฉ ูู ุงูููุงูุฉ
316
00:26:36,570 --> 00:26:42,350
ุงูู
ุดููุฉ ูู ูุฐุง ุงูู
ุฑุถ ุฃูู there is not a systemic
317
00:26:42,350 --> 00:26:47,030
pathway ูุนูู ู
ุง ููุด ุทุฑูู ูุนูู ูุนูู ู
ุด ูู ู
ุฑุฉ ุงูู
ุฑุถ
318
00:26:47,030 --> 00:26:54,910
ุจูุณูู ููุณ ุงูุชุณูุณู ูู ุงููู ูู ุชุฎุฑูุจ ุฃุนุถุงุก ุงูุฌุณู
319
00:26:54,910 --> 00:26:58,970
ุฃุณูู patient produce antibodies against several
320
00:26:58,970 --> 00:27:02,490
nuclear components ู
ููุง ุงูู antinuclear antibody
321
00:27:03,020 --> 00:27:08,620
ูุคูุงุก ุฃูุถุง ู
ุตุงุฏุฑ ุถุฏ ุงูู Denaturated Single
322
00:27:08,620 --> 00:27:17,620
-Stranded DNA ูุถุฏ ููููููููุณุชูุฒ ุงูู Anti-Double
323
00:27:17,620 --> 00:27:24,440
-Stranded DNA ุทุจุนุง
324
00:27:24,440 --> 00:27:27,460
ุจูุดููู ุจูุซุฑุฉ ูู ุงููุงุณ ุงููู ุนูุฏูู
ุฎูุงู ูุฑููุฉ ุงู
325
00:27:27,460 --> 00:27:34,170
involvement ูู ุงูุฃุณุฆูุฉ E ุงูุฅูุฌู ุฃู
ุงูุฃูุชูุจูุฏูุงุช
326
00:27:34,170 --> 00:27:37,550
ุชูุชุฌ ู
ู ุฃุฌู ุงูู Single-Strand DNA ูู
ูููุง ุฃู ุชุชุนุงู
ู
327
00:27:37,550 --> 00:27:42,490
ู
ุน ุชุบููุฑ ุฅูุฒูุชูุจู ูุชูุชุฌ ุฅูุฌู ุฌู ุนุงูู ุงููููุชู ุงูู
328
00:27:42,490 --> 00:27:48,490
Double-Strand DNA ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู ..
329
00:27:48,490 --> 00:27:49,910
ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู ..
330
00:27:49,910 --> 00:27:51,630
ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู ..
331
00:27:51,630 --> 00:27:54,770
ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู .. ูุชุนุงู
ู ..
332
00:27:54,770 --> 00:27:56,470
ูุชุนุงู
ู .. ูุชุนุงู
ู ..
333
00:28:00,190 --> 00:28:05,350
Trapping of IgG Antibody or Anti-Double-Stranded
334
00:28:05,350 --> 00:28:11,990
DNA ุจูุคุฏู ูุชูููู Immune Complexes ูู ุงูู glomerulus
335
00:28:11,990 --> 00:28:18,690
ูุทุจุนุง ูุฐุง ุจูุคุฏู ูุชูุดูุท ุงูู complement ูุจุนู
ู
336
00:28:18,690 --> 00:28:24,910
recruitment ููู granulocytes ูู
ุญุตูุฉ ุฑููุงู ุฏุงู
ุฌ Anti
337
00:28:24,910 --> 00:28:27,970
-Double-Stranded DNA Antibody ุจู cross-react
338
00:28:27,970 --> 00:28:33,660
ููู glomerulus ููู ุทุจุนุง ุฒู ุงูู extent of inflammatory
339
00:28:33,660 --> 00:28:41,480
reaction ุจุชุนุชู
ุฏ ุนูู ุฃู ูู ู
ู ูุญุฏุฏ severity of
340
00:28:41,480 --> 00:28:45,820
kidney pathology ุงูู
ุญุตูุฉ
341
00:28:45,820 --> 00:28:48,840
ุงููู ูููุงู glomerulonephritis ู ุงูู severity ุทุจุนุง
342
00:28:48,840 --> 00:28:53,580
ุจุชุคุฏู ุฅูู leakage of protein ู
ู ุงูู blood ู
ู ุงูู
343
00:28:53,580 --> 00:29:00,740
kidney ููู ู
ุง ุตุงุฑุช ุงูุญุงูุฉ chronic Inflammatory CD4
344
00:29:00,740 --> 00:29:06,200
ุงููู ุฏู ุงูู protein ุงููู ูุชูุดุทููุง ุงูู macrophage ู ุงู
345
00:29:06,200 --> 00:29:10,600
can attract monocytes ุงูู macrophage ูุจุงูุชุงูู ูุฐุง
346
00:29:10,600 --> 00:29:17,140
ุจูุคุฏู ุฅูู pathological lesion ูrenal failure ุฃุณุฆูุฉ
347
00:29:17,140 --> 00:29:21,360
ูู
ุงู ู
ู
ูู ุชูุชุฌ ูุชูุฌุฉ ุงูู exposure to some common
348
00:29:21,360 --> 00:29:26,110
environmental factor ุฒู ุงูู ultraviolet light ูุฑู
ูู
349
00:29:26,110 --> 00:29:30,050
ูุฅูููุณููุฒ ุงูุฌุงูุฒ ูุนูู ู
ุด ุชุนู
ู ุจูู ููุฑูุณ ููููู
ุจูุนุจ
350
00:29:30,050 --> 00:29:38,710
ุฏูุฑ ูู ุงูู etiology of disease ูุนูู
351
00:29:38,710 --> 00:29:44,670
you can cross react with nuclear antigen induction
352
00:29:44,670 --> 00:29:51,030
ุฃูุถุง by drugs ุฒู ุงูู penicillamine ูููุฑู ุจุฑู
ุงุฒูู
353
00:29:51,030 --> 00:29:57,110
ููุฏุฑุงุฒููุงูุดูุก ุงููู ูุญุฏุซ ูู ุฃู ู
ุตุงุฏุฑ ุงูุงูุชุฑููููุงุช
354
00:29:57,110 --> 00:30:01,430
ุชูุชุฌ ู
ุตุงุฏุฑ ุงูุงูุชุฑููููุงุช ูุดุฎุต ูุงุญุฏ.ูู ุงูุบุฑุจุ
355
00:30:01,430 --> 00:30:02,170
ุงูู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ
356
00:30:02,170 --> 00:30:03,170
ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู
357
00:30:03,170 --> 00:30:06,790
ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง
358
00:30:06,790 --> 00:30:08,710
ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ
359
00:30:08,710 --> 00:30:12,710
ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู
360
00:30:12,710 --> 00:30:15,650
ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง ููู
ุตุงุฏุฑ ุงููู ุชุฏูุนูุง
361
00:30:15,650 --> 00:30:21,690
ููู
ุตุงุฏุฑ ุงูููุจูุฌู ูููุน ุชุงูู ู
ู ุงูู autoimmune
362
00:30:21,690 --> 00:30:25,890
disease ุงููู ุจูููู ูู ุชููููููุณุงูุช ุงูุนุจุฏุงููุจูุฑ in
363
00:30:25,890 --> 00:30:31,810
organ damage ููุญูู ุนูู multiple sclerosis ูู ุงู
364
00:30:31,810 --> 00:30:39,070
multiple sclerosis ุงููู ุจูุตูุฑ ููู demyelination of
365
00:30:39,070 --> 00:30:45,050
central nervous system tissue ุจูููุฑู
366
00:30:45,050 --> 00:30:52,600
ุงูู myelin sheath ูุงุญุฏุฉ ุจููุฏู ุฅูููุง relapse or remitting
367
00:30:52,600 --> 00:30:57,600
or progressive paralytic course ูุนูู ุจุญุตููุง ูู
368
00:30:57,600 --> 00:31:03,100
ุงูุบุงูุจ ุดูู ููุจุฑูุฏ ูุฃู ุงูู myelin sheath ูู
369
00:31:03,100 --> 00:31:10,380
ุงูู
ุณุฆููุฉ ุนู ุงูู neurotransmitter ููุฑู ุณูุฌุงู it's
370
00:31:10,380 --> 00:31:13,240
considered to be a T cell mediated autoimmune
371
00:31:13,240 --> 00:31:17,980
disease ูุงููู ุจูุตูุฑ ูู cellular infiltrate
372
00:31:17,980 --> 00:31:21,010
associated with T ุงูู protein ูุงูููุน Delete type of
373
00:31:21,010 --> 00:31:27,490
sensitivity mechanism class two ุฃู
ุฏุดู ู
ููููููู
374
00:31:27,490 --> 00:31:35,570
ุจููุนุจ ุฏูุฑ ูุจูุฑ ูู ุงูู disease susceptibility ุงูุฑุงุจุท
375
00:31:35,570 --> 00:31:38,390
ูุนูู ุงููู ูู type one insulin diabetes mellitus
376
00:31:38,390 --> 00:31:44,710
insulin dependent diabetes mellitus ู
ุฌุฑุฏ chronic
377
00:31:44,710 --> 00:31:48,670
inflammatory destruction of the beta cell
378
00:31:50,840 --> 00:31:55,160
ูู ุงูุจููุฑูุงุณ ููู ุนุจุงุฑุฉ ุนู insulin producing beta
379
00:31:55,160 --> 00:32:02,060
islet cell of the ุจููุฑูุงุณ ูุทุจุนุง ุงูู
ุณุฆูู ุงูู
ุจุงุดุฑ ูู
380
00:32:02,060 --> 00:32:05,340
ูุฐุง ุงูู
ูุถูุน ูู cytotoxic T cell ุงูุชู ุชููุงุฌู
ูุฐู
381
00:32:05,340 --> 00:32:13,420
ุงูุฎูุงูุง ูุชูููุฏ cytokine ูุงูู
ููุก ุฃูุถูุง ุจุชุคุฏู ุฅูู
382
00:32:13,420 --> 00:32:18,080
antibody production ุชููุงุฌู
ุงูุฎูุงูุง
383
00:32:28,320 --> 00:32:34,580
ุงููุณุจุฉ ูู HLA type HLA
384
00:32:34,580 --> 00:32:39,140
type HLA
385
00:32:39,140 --> 00:32:41,700
type HLA type HLA type HLA type
386
00:32:41,700 --> 00:32:41,980
HLA type HLA type HLA type HLA
387
00:32:41,980 --> 00:32:42,040
type HLA type HLA type HLA type
388
00:32:42,040 --> 00:32:42,240
HLA type HLA type HLA type HLA
389
00:32:42,240 --> 00:32:44,580
type HLA type HLA type HLA type ููุฌุฏ ุฃู
390
00:32:44,580 --> 00:32:47,880
50% ู
ู Insulin Dependent ู
ุฑุถ ุงุณู
ู latest
391
00:32:47,880 --> 00:32:54,320
patient ุนูุฏูู
HLA-DR3 ุฃุฑุจุนุฉ ููุชูุฑูุฒุงูุฏุฒ positive ู
392
00:32:54,320 --> 00:33:02,660
individuals with HLA-DQP1 ุงูุฐู ูู 0602 rarely
393
00:33:02,660 --> 00:33:07,520
develop the disease Hashimoto's
394
00:33:07,520 --> 00:33:14,360
thyroiditis ู
ูุฌูุฏ ูู the middle aged women ูุคุฏู ูู
395
00:33:14,360 --> 00:33:20,140
Formation of Goiter ูุทุจุนุง ุงูู
ุญุตูุฉ Atrophy of the
396
00:33:20,140 --> 00:33:24,020
thyroid gland ุงูุฐู ูุคุฏู ูู ุงูููุงูุฉ ูู
397
00:33:24,020 --> 00:33:27,400
Hypothyroidism and Destruction of the thyroid
398
00:33:27,400 --> 00:33:34,040
function ุบุงูุจุง ุงูู
ุฑุถ associated with T cell ููู ุงู
399
00:33:34,040 --> 00:33:39,920
antibody ุชูุนุจ ุฏูุฑูุง ูุจูุฑูุง ูู ุงูู
ุฑุถ Target antigen
400
00:33:39,920 --> 00:33:44,190
include thyroglobulinุ ุงูู
ููุฑูุฒูู
ุงู ุงูุชูุฌูู ู
ู ุงูู
401
00:33:44,190 --> 00:33:48,530
Thyroid Epithelial Cellุ ู Antibodies of these antigens ุชู
402
00:33:48,530 --> 00:33:55,450
ุงูุชุดุงููุง. Infiltration of B cell andonuclear B cell and
403
00:33:55,450 --> 00:34:00,050
nuclear T cell and microfollicle ูุคุฏู ุฅูู ุงูุงูุชูุงู ูุฅุฏู
ุงุฌ ู
ู
404
00:34:00,050 --> 00:34:06,310
the thyroid follicle ูุจุงูุชุงูู ุงูุบุฏุฉ ุชุญุงูู ุงูุงูุชูุงู
405
00:34:06,310 --> 00:34:11,640
ูุชุตุจุญ ูุจูุฑุฉ ุฑุฏ ูุนู ุทุจูุนู ุฅูู ุชุนู
ู
406
00:34:11,640 --> 00:34:16,940
Regeneration ูุจุงูุชุงูู ุชุจุฏุฃ ุชูุจุฑ when destruction
407
00:34:16,940 --> 00:34:23,380
continues Symptoms of hypothyroidism appear ู
ุซุงู
408
00:34:23,380 --> 00:34:29,000
ุขุฎุฑ when one has arthritis chronically inflamed
409
00:34:29,000 --> 00:34:37,010
synovium ููุตุจุญ ู
ุฒุฏุญู
ุจูุซุงูุฉ ู
ุน lymphocyte
410
00:34:37,010 --> 00:34:43,690
ู
ุญุตูุฉ destruction of the cartilage and bone ุทุจุนุง
411
00:34:43,690 --> 00:34:49,710
Synovium is densely packed with dendritic cell,
412
00:34:49,810 --> 00:34:53,890
macrophage, T cell, B cell, NK cell, and clumps of
413
00:34:53,890 --> 00:34:57,790
plasma cell ููู ุจุนุถ ุงูุฃุญูุงู ูุตุจุญ ููู secondary
414
00:34:57,790 --> 00:35:04,620
follicle Pathology ูู ุนุจุงุฑุฉ ุนู ู
ุญุตูุฉ
415
00:35:04,620 --> 00:35:08,240
ูู mixture of immunopathological mechanism ุฎุตูุตุง
416
00:35:08,240 --> 00:35:11,680
Immune Complexes Formation Complement
417
00:35:11,680 --> 00:35:16,610
Activity Polymorphic Nuclear Infiltration ูุงูู
418
00:35:16,610 --> 00:35:21,230
inflammatory CD4 ูุงูู CD8 ูุงูู cytotoxic T
419
00:35:21,230 --> 00:35:25,870
-lymphocyte ู
ุน ุงูู activated macrophage ูุงูู unk
420
00:35:25,870 --> 00:35:29,890
cell ูุงูู cell-mediated immunity ูููุง ุงุจุชุฏุงู ุนู
421
00:35:29,890 --> 00:35:30,150
ุฐูู
422
00:35:35,260 --> 00:35:38,900
A variety of cytokines ูููู
ุนุจุงุฑุฉ ุนู ุฎูุงูุง ู
ุจุทูุฉ
423
00:35:38,900 --> 00:35:43,020
ูููู
ูููุฑุฒูู cytokine ุฃุดูุฑ ูุฐุง ุงู cytokine human
424
00:35:43,020 --> 00:35:47,720
necrosis factor alpha ู IL-1 ู degradative enzymes
425
00:35:47,720 --> 00:35:52,380
ู ุจุนุถ ุงู mediators that destroy the integrity of
426
00:35:52,380 --> 00:35:57,840
cartilage Chondrocytes ุฎูุงูุง ุงูุบุถุฑูู ุทุจุนุง
427
00:35:57,840 --> 00:36:02,360
ุชุตุจุญ ู
ูุดููุฉ ููุฌูุงุฒ ุงูู
ูุงุนู ุณูููุง ุงููููุฏ
428
00:36:02,360 --> 00:36:07,690
ูู ุงูุบุงูุจ ุชุชุฌู
ุน ูู ุฌุฏุงุฑ ุงูู Arthritis ุงูุฑูู
ุงุชููุฉ
429
00:36:07,690 --> 00:36:13,330
ููุญุชูู ุนูู ุนุฏุฏ ูุจูุฑ ู
ู Polymorphic Nuclear Cell
430
00:36:13,330 --> 00:36:23,170
ูุงูููุจุฑูู
431
00:36:23,170 --> 00:36:28,390
ุชู
ุชุฑุณูุจู ููุชู
ุชุฑุณูุจู ุจุงูููุจุฑุงุณุชูุดู ูุฌุฏุงุฑ
432
00:36:28,390 --> 00:36:30,290
ุงูุฃููููุฒ
433
00:36:36,600 --> 00:36:46,060
IgM ุฑูู
ุงุชููุฏ ูุงูุชูุฑ ูุฑุชุจุท ุจุฌุฒุก Fc
434
00:36:46,060 --> 00:37:01,280
ูู IgG ุงูุทุจูุนู ุนูู ุฌุฒูุก IgG ุฑูู
ุงุชููุฏ
435
00:37:01,280 --> 00:37:09,770
ูุงูุชูุฑ ู
ููุฏ of disease activity ูุบุงูุจุง
436
00:37:09,770 --> 00:37:15,590
ูุฌุฏูู ูุตู ุฅูู remission during ูุตุจุญ ููู ู
ุณุชูู ู
ูุฎูุถ
437
00:37:15,590 --> 00:37:22,270
during remission ู
ุซุงู ุงูุฃุฎูุฑ ุฃุธู ุฃู ุงู autoimmune
438
00:37:22,270 --> 00:37:28,620
disease ุงูุฐู ูุงุชุฌ ุนู ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
439
00:37:28,620 --> 00:37:33,700
ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
440
00:37:33,700 --> 00:37:35,840
ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
441
00:37:35,840 --> 00:37:41,820
ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
442
00:37:41,820 --> 00:37:41,880
ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
443
00:37:41,880 --> 00:37:42,360
ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
444
00:37:42,360 --> 00:37:51,720
ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช ูู
ุจูู
ูุช
445
00:37:51,950 --> 00:37:55,510
Complement Clearance Mechanism as in Serum
446
00:37:55,510 --> 00:38:00,750
Sickness ูุนูู ูุง ูุตููุง Clearance Deficiency in
447
00:38:00,750 --> 00:38:06,190
complement 4 ููุตุฏ ุซูุงุซุฉ ูุคุฏู ูู ุงููุดู to clear
448
00:38:06,190 --> 00:38:11,770
immune complexes by macrophage ุฃุณุฃู ู
ุงุฐุง ูุญุฏุซ ุฃูุซุฑ
449
00:38:11,770 --> 00:38:14,530
ู
ู 80% ู
ู ุงูุฃูุฑุงุฏ ุนูุฏูู
complement
450
00:38:14,530 --> 00:38:17,930
deficiency of C1 ูC4 ูC2
451
00:38:21,850 --> 00:38:26,150
Therapeutic Strategies ู
ุงุฐุง ููุนููู ูู ูุฐู ุงูุญุงูุฉุ ููุนููู
452
00:38:26,150 --> 00:38:29,470
Cytotoxic Drugs ู
ุซู ุงูู cyclophosphamide ูุงูู
453
00:38:29,470 --> 00:38:36,060
azathioprine ูุคูุงุก ูููุงุฌู
ูู DNA Replication ููููุงุฌู
ูู
454
00:38:36,060 --> 00:38:43,780
ุจุดูู ุฃุณุฑุน ุฌุณู
ุงูุจุทุงูุฉ ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู
455
00:38:43,780 --> 00:38:44,420
ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู
456
00:38:44,420 --> 00:38:47,100
ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู
457
00:38:47,100 --> 00:38:47,140
ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู
458
00:38:47,140 --> 00:38:47,220
ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู
459
00:38:47,220 --> 00:38:55,540
ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู ุฃุณุฑุน ุจุดูู
460
00:38:55,540 --> 00:39:02,200
Anti Cytokine Therapy ุจูู ุฃู tumor necrosis factor
461
00:39:02,200 --> 00:39:06,060
alpha by antibody or soluble receptor for
462
00:39:06,060 --> 00:39:10,580
rheumatoid arthritis. Inhibition of IL-1 beta by
463
00:39:10,580 --> 00:39:16,360
soluble receptor also seems a useful strategy in
464
00:39:16,360 --> 00:39:22,280
rheumatoid arthritis. These immunomodulatory agents
465
00:39:23,780 --> 00:39:27,020
ุชูู
ูุญูุง ุงูููุงู
ุงุช ุฑุฏูุฏ ุทุจุนุง ุฅุฐุง ุนู
ููุง Blockage
466
00:39:27,020 --> 00:39:33,680
ูู IL-1 beta ูููู ูุดุงุทู interferon beta ูู
467
00:39:33,680 --> 00:39:38,400
ูุณุชุฎุฏู
ููุชุนุงู
ู ู
ุน ุงูุชุตูุจ ุงูู
ุชุนุฏุฏ ู
ู ุฎูุงู
468
00:39:38,400 --> 00:39:44,820
ุงูู antibody ุฅูู CD3 ุจุฑุถู ูุญุตูู ุฌูุฏูุง ูู ุงู
469
00:39:44,820 --> 00:39:51,180
autoimmune diabetes Costimulatory Blockade ู
ุซู ุงู
470
00:39:52,450 --> 00:39:56,170
ุทุจุนุง CTLA-4 ู Blockade ุชุธูุฑ
471
00:39:56,170 --> 00:40:00,830
promising ูู rheumatoid arthritis and psoriasis ุจูุทู
472
00:40:00,830 --> 00:40:06,610
ุจุจุชูุฏุงุช that bind to MHC group but not capable of
473
00:40:06,610 --> 00:40:11,230
activating a given T cell have been used to induce
474
00:40:11,230 --> 00:40:17,010
tolerance in rodent models ูุนูู ุฃุฏุฎููุง ุจุจุชูุฏ ุชุฑุชุจุท
475
00:40:17,010 --> 00:40:20,590
ุจุงูู MHC molecule ูุจุงูุชุงูู ุฎูุงุต ู
ุดุบูู ู
ุง ููุด
476
00:40:20,590 --> 00:40:26,190
ุฅู
ูุงููุฉ ุฃูู ุชุนู
ู ุงูุฎูุงูุง ุชุนู
ู Antigen Presentation
477
00:40:26,190 --> 00:40:31,410
T cell receptor have been administered to patients
478
00:40:31,410 --> 00:40:38,310
as an immunogen in an effort to raise a clonotype
479
00:40:38,310 --> 00:40:41,270
specific cytotoxic T cell
480
00:40:44,980 --> 00:40:52,700
ูุนูู ููุง ุฃุฏุฎููุง Receptor ูุญุตูุช ุนูู ุงุนุชุจุงุฑ ุงูุฌุณู
481
00:40:52,700 --> 00:40:57,220
ูู
ุณุชุถุฏ ูุทุจุนุง ูุดุฑุช ููุง site toxic T lymphocyte
482
00:40:57,220 --> 00:41:02,900
ุงูุชู ุนู
ูุช destruction ููุฎูุงูุง generation of T
483
00:41:02,900 --> 00:41:07,460
suppressor cell in autoimmune individuals ุจุฑุถู ูุฐุง
484
00:41:07,460 --> 00:41:14,350
ุนุจุงุฑุฉ ุนู ุนูุงุฌ ุทุจุนุง ูู ุงู autoimmune disease ูุงูู
485
00:41:14,350 --> 00:41:20,030
MHC association with which ุงูุฃููู commonly found
486
00:41:20,030 --> 00:41:25,830
strength of association ุงูุนูุงูุฉ ุจูู ุงูุฃู
ุฑุงุถ ูุงูู
487
00:41:25,830 --> 00:41:31,610
MHC ุฌูู ูุงูุฃููู ุงูุชู ุชููู ู
ูุฌูุฏุฉ ุทุจุนุง ูุฐุง ุนูุงูุฉ
488
00:41:31,610 --> 00:41:38,010
ู
ูุชูุจุฉ strength ุฃู weak ูุนูู ูุฌูุฏ ุงูุฃููู ุงูุชู ุชุจุน
489
00:41:38,010 --> 00:41:44,660
ุงูู MHC molecule ู
ุงุดู ุจูุฐู ุงูุงูุงู
ุจูุคุฏู ุฅูู ุฃู
490
00:41:44,660 --> 00:41:49,040
ุงูู
ุฑุถ ูุตุจุญ high risk of age inducing such diseases
491
00:41:49,040 --> 00:41:54,740
ุฃูุง
492
00:41:54,740 --> 00:41:57,780
ุงู autoimmune disease ูุงู auto antigen ุงูุชู
493
00:41:57,780 --> 00:42:05,920
ููุณู
ู ู
ูุงุฌู
ุฉ ูู
ูู ุงูุฐู ูููุงุฌู
ู
ูู
494
00:42:05,920 --> 00:42:14,640
ุงูุฐู ูููุงุฌู
ูุจูุฐุง ูููู ูุฏ ุฃููููุง ุงูู
ุญุงุถุฑุฉ ุดูุฑูุง
495
00:42:14,640 --> 00:42:15,480
ุจุงูู
ุชุงุจุนุฉ
|